USC is growing its medical enterprise by acquiring Orange Coast Oncology Hematology (OCOH) in Orange County. This acquisition brings together Keck Medicine of USC and USC Norris Comprehensive Cancer Center with OCOH to provide exceptional oncology care across Southern California.
A highly respected oncology practice that sees more than 5,000 patients a year. Now called USC Norris Oncology/Hematology, the practice includes two clinic locations: one at Hoag Memorial Hospital Presbyterian in Newport Beach and one in Irvine. USC Norris Oncology/Hematology also has an infusion center in Newport Beach. These offices and staff became a part of Keck Medicine of USC on July 4. Additionally, the five physicians – Louis VanderMolen, MD, George Semeniuk, MD, Greg Angstreich, MD, Minh Nguyen, MD, and Dilruba N. Haque, MD — are now faculty at the Keck School of Medicine of USC and members of the USC Care Medical Group.
“For some time, we have recognized the need to take the innovations of USC Norris far beyond the USC Health Sciences Campus,” explains Tom Jackiewicz, senior vice president and CEO for USC Health. “Our goal has been to build a system of cancer programs with satellites across Southern California. Today, we are one step closer to realizing this goal.”
Through this acquisition, Keck Medicine of USC brings the services of USC Norris — one of the National Cancer Institute’s eight original designated comprehensive cancer centers in the United States — to Orange County. That includes a rich, 40-year history of global research, compassionate clinical care, groundbreaking clinical trials, tumor boards and genetic stem cell research.
Leveraging this Orange County group’s expertise in outpatient oncology services, Keck Medicine of USC will expand its complete range of world-class cancer care to patients in Orange County by bringing the best university-based medical center offerings to an outpatient clinic.
Stephen Gruber, MD, director of USC Norris Comprehensive Cancer Center, explained, “For our patients, this means access to leading technology, advanced clinical trials, the world’s best oncologists, an expanding faculty base that continues to recruit top tier clinicians, and the newest cancer therapies.”
He added, “By providing this kind of world-class care closer to home, we know we will be making a significant impact in the lives of the patients and families in Southern California who entrust their care to us.”